Cite
HARVARD Citation
Hanauer, S. et al. (n.d.). A Randomized, Double‐Blind, Placebo‐Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study. American journal of gastroenterology. p. . [Online].